Figure 1 (Qal00 0001 01)
Qalsody Injection
Product Images NDC 64406-109
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Qalsody (NDC 64406-109). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Biogen Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 2 (Qal00 0001 02)
Principal Display Panel (Carton Label)
This text is a product description for Tofersen Injection, intended for Intrathecal Injection Only. It should be stored refrigerated between 2C to 8°C and not frozen. Each 1 mL contains tofersen (6.7 mg), calcium chloride dihydrate (0.21 mg), dibasic sodium phosphate (0.1 mg, magnesium chloride hexahydrate (0.16 mg), monobasic sodium phosphate (0.03 mg), potassium chloride (0.22 mg), sodium chloride (8.7 mg), and water for injection. The recommended dosage is not specified.*
Principal Display Panel (Vial Label)
This text provides information about a medication called ART05607, which is a sterile solution for intrathecal injection only. The medication is supplied in single-dose vials and the recommended dosage needs to be obtained from the prescribing information. Instructions for storage are provided as well, including a temperature range of 2°C to 8°C and protection from light. The medication is manufactured by Biogen MA Inc., and their contact information is provided.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
